Berlin - Delayed Quote EUR
Medivir AB (MVR0.BE)
0.1380
-0.0032
(-2.27%)
At close: 8:08:14 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,584
3,484
7,634
4,408
25,537
Operating Expense
117,655
131,555
100,386
93,016
89,938
Operating Income
-114,071
-128,071
-92,752
-88,608
-64,401
Net Non Operating Interest Income Expense
-1,909
-709
-886
-920
-950
Pretax Income
-110,517
-123,317
-89,322
-88,765
-62,579
Tax Provision
0
0
0
0
546
Net Income Common Stockholders
-110,517
-123,317
-89,322
-88,765
-63,125
Diluted NI Available to Com Stockholders
-110,517
-123,317
-89,322
-88,765
-63,125
Basic EPS
-0.97
--
-1.48
-1.59
-0.98
Diluted EPS
-0.97
--
-1.48
-1.59
-0.98
Basic Average Shares
114,476
--
60,438
55,736
64,465.3670
Diluted Average Shares
114,476
--
60,438
55,736
64,465.3670
Total Operating Income as Reported
-113,241
-127,341
-91,414
-87,354
-62,118
Total Expenses
117,655
131,555
100,386
93,016
89,938
Net Income from Continuing & Discontinued Operation
-110,517
-123,317
-89,322
-88,765
-63,125
Normalized Income
-115,250
-128,050
-92,299
-88,309
-64,053.9800
Interest Income
--
73
27
8
0
Interest Expense
--
782
913
928
950
Net Interest Income
-1,909
-709
-886
-920
-950
EBIT
-108,535
-122,535
-88,409
-87,837
-61,629
EBITDA
-105,807
-119,807
-85,668
-85,266
-59,034
Reconciled Depreciation
2,728
2,728
2,741
2,571
2,595
Net Income from Continuing Operation Net Minority Interest
-110,517
-123,317
-89,322
-88,765
-63,125
Total Unusual Items Excluding Goodwill
4,733
4,733
2,977
-456
1,170
Total Unusual Items
4,733
4,733
2,977
-456
1,170
Normalized EBITDA
-110,540
-124,540
-88,645
-84,810
-60,204
Tax Rate for Calcs
0
0
0
0
0.0002
Tax Effect of Unusual Items
0
0
0
0
241.0200
12/31/2021 - 9/13/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HTD.F Corcept Therapeutics Incorporated
62.84
+3.02%
A71.F Ascendis Pharma A/S
151.00
+0.67%
2LB.F Iovance Biotherapeutics, Inc.
2.0990
+7.77%
MDG1.F Medigene AG
0.1300
+6.12%
ALCOX.PA Nicox S.A.
0.2290
+0.66%
ALTME.PA TME Pharma N.V.
0.0844
-2.65%
NWRN.SW Newron Pharmaceuticals S.p.A.
7.66
-0.52%
PRTC.L PureTech Health plc
139.00
-0.57%
VLA.PA Valneva SE
2.7320
+2.48%
ZEAL.CO Zealand Pharma A/S
497.00
+4.32%